PH25649A - Basic formuations of quinolonecarboxylic acid - Google Patents

Basic formuations of quinolonecarboxylic acid

Info

Publication number
PH25649A
PH25649A PH33258A PH33258A PH25649A PH 25649 A PH25649 A PH 25649A PH 33258 A PH33258 A PH 33258A PH 33258 A PH33258 A PH 33258A PH 25649 A PH25649 A PH 25649A
Authority
PH
Philippines
Prior art keywords
basic
formuations
quinolonecarboxylic acid
methyl
acid
Prior art date
Application number
PH33258A
Other languages
English (en)
Inventor
Arundev Haribhai Naik
Herbert Voege
Gerhard Schluter
Klaus Grohe
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25828371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH25649(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PH25649A publication Critical patent/PH25649A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Silicon Polymers (AREA)
  • Noodles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH33258A 1985-01-05 1986-01-03 Basic formuations of quinolonecarboxylic acid PH25649A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3500243 1985-01-05
DE19853517709 DE3517709A1 (de) 1985-01-05 1985-05-17 Basische zubereitungen von chinoloncarbonsaeuren

Publications (1)

Publication Number Publication Date
PH25649A true PH25649A (en) 1991-08-21

Family

ID=25828371

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33258A PH25649A (en) 1985-01-05 1986-01-03 Basic formuations of quinolonecarboxylic acid

Country Status (18)

Country Link
US (1) US4772605A (hu)
EP (1) EP0187315B1 (hu)
KR (1) KR890002240B1 (hu)
CN (2) CN1011572B (hu)
AT (1) ATE62595T1 (hu)
AU (1) AU563777B2 (hu)
CA (1) CA1273578A (hu)
DE (2) DE3517709A1 (hu)
DK (1) DK165666C (hu)
ES (3) ES8802423A1 (hu)
FI (1) FI87425C (hu)
GR (1) GR860008B (hu)
HU (1) HU194735B (hu)
IE (1) IE58450B1 (hu)
IL (1) IL77506A (hu)
NO (1) NO172674C (hu)
PH (1) PH25649A (hu)
PT (1) PT81792B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPH0696533B2 (ja) * 1987-01-14 1994-11-30 北陸製薬株式会社 キノロンカルボン酸の水性組成物
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
US5084276A (en) * 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
IT1270836B (it) * 1993-10-27 1997-05-13 Archimica Spa Procedimento per la preparazione di rufloxacina e suoi sali
EP0868183B1 (en) * 1995-12-21 2002-01-30 Pfizer Inc. Injectable quinolone formulations
IN186245B (hu) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
JP4331944B2 (ja) * 2001-04-17 2009-09-16 大日本住友製薬株式会社 新規アデニン誘導体
US6872723B2 (en) * 2002-01-28 2005-03-29 Wyeth Stabilized difloxacin injectable solution
CN101480384A (zh) * 2002-12-17 2009-07-15 阿伯特有限及两合公司 包含非诺贝酸、其生理可接受的盐或衍生物的制剂
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20060073117A1 (en) * 2004-10-01 2006-04-06 Stowers Institute For Medical Research Methods and compositions for controlling hair follicle stem cell fate
DE102004054873A1 (de) 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
EP3034078A1 (en) 2010-09-27 2016-06-22 Emergent Product Development Gaithersburg Inc. 2-pyridone antimicrobial compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019910B2 (ja) * 1979-10-11 1985-05-18 大塚製薬株式会社 ベンゾ〔ｉｊ〕キノリジン−２−カルボン酸誘導体及びその製造法
DE2953974C2 (hu) * 1978-04-12 1992-06-25 Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5551422A (en) * 1978-10-11 1980-04-15 Takeda Chem Ind Ltd Deodorization
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4404197A (en) * 1981-05-15 1983-09-13 Fox Jr Charles L Antimicrobial compositions containing 1-ethyl-6-fluoro-1,4-dihydro-4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid or metal salts thereof and silver sulfadiazine
HU188181B (en) * 1981-06-11 1986-03-28 Warner-Lambert Co,Us Process for producing salts of naphtiridine and quinoline compounds of antimicrobial activity
DE3225367A1 (de) * 1982-07-07 1984-01-12 Hoechst Ag, 6230 Frankfurt Arzneimittel zur behandlung von infektioes bedingten diarrhoeen
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics

Also Published As

Publication number Publication date
DE3582575D1 (de) 1991-05-23
AU563777B2 (en) 1987-07-23
CN1011572B (zh) 1991-02-13
PT81792A (en) 1986-02-01
FI87425C (fi) 1993-01-11
IL77506A (en) 1990-03-19
EP0187315B1 (de) 1991-04-17
FI860010A (fi) 1986-07-06
HU194735B (en) 1988-03-28
DE3517709A1 (de) 1986-07-10
CA1273578A (en) 1990-09-04
ATE62595T1 (de) 1991-05-15
FI87425B (fi) 1992-09-30
ES557771A0 (es) 1988-04-01
NO172674C (no) 1993-08-25
ES557770A0 (es) 1989-03-16
KR860005635A (ko) 1986-08-11
PT81792B (pt) 1988-05-27
DK2386A (da) 1986-07-06
CN1040143A (zh) 1990-03-07
DK165666B (da) 1993-01-04
EP0187315A2 (de) 1986-07-16
AU5104685A (en) 1986-07-10
IE58450B1 (en) 1993-09-22
KR890002240B1 (ko) 1989-06-26
ES550668A0 (es) 1988-06-01
NO172674B (no) 1993-05-18
HUT40329A (en) 1986-12-28
ES8802150A1 (es) 1988-04-01
EP0187315A3 (en) 1987-08-12
DK2386D0 (da) 1986-01-03
GR860008B (en) 1986-04-25
ES8900196A1 (es) 1989-03-16
NO855094L (no) 1986-07-07
US4772605A (en) 1988-09-20
IE860018L (en) 1986-07-05
ES8802423A1 (es) 1988-06-01
DK165666C (da) 1993-06-01
FI860010A0 (fi) 1986-01-02
CN85109451A (zh) 1986-09-10

Similar Documents

Publication Publication Date Title
PH25649A (en) Basic formuations of quinolonecarboxylic acid
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
DE3650315D1 (de) Cyancrotonsäureamidverbindung als Arzneimittel mit immunmodulierenden Eigenschaften.
FI845126A0 (fi) Nya pyridin-2-etrar och pyridin-2-tioetrar med en kvaevehaltig cykloalifatisk ring.
EP0216345A3 (en) Quinoline derivatives
NZ229861A (en) 2,5,6-trisubstituted pyridine-3-carboxylic acids and acid derivatives
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
FI864970A0 (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
EP0535250A4 (en) Novel compounds and use thereof as medicine
EP0194579A3 (en) 3-pyridylmethylnaphthyl derivatives, process for their preparation and their use as medicaments
ZA841418B (en) N-arylpiperazine derivatives
IT1241515B (it) Sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico".
ES8707499A1 (es) Un metodo para preparar derivados de indol